The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.
暂无分享,去创建一个
C. Coarfa | A. Marian | A. Braza-Boïls | M. Robertson | Priyatansh Gurha | P. Molina | E. Zorio | J. Gimeno | Yan Yao | M. S. Molina | Sirisha M Cheedipudi | L. Rouhi | S. Fan | A. Braza‐Boïls | Ali J Marian | A. J. Marian